All Posts

Centiloid Scale Standardization for Dementia Research

Positron Emission Tomography (PET) imaging of amyloid‑β plaques plays a central role in Alzheimer’s disease (AD) research. However, variability across tracers, scanners, and processing pipelines can make results difficult to compare between studies. The Centiloid (CL) scale was developed to address this issue by providing a standardized, tracer‑independent framework for quantifying amyloid burden. What is the Centiloid Scale? The Centiloid scale expresses amyloid PET results

Neuroimaging Workshop on Diagnosis and Disease Treatment for Early Symptomatic Alzheimer's Disease

19 July 2025 - Workshop The Chairman of the workshop - Prof. Henry Mak Alzheimer's disease is a growing concern as our global population...

Amyloid-related imaging abnormalities (ARIA)

Anti-amyloid treatments for Alzheimer's disease (AD) can lead to a side effect called Amyloid-Related Imaging Abnormalities (ARIA), which...

Exploring the Role of Magnetic Resonance Spectroscopy in Understanding Alzheimer's Disease Normal Aging and Psychosis

Magnetic Resonance Spectroscopy (MRS) is a powerful, non-invasive imaging tool that helps researchers gain insights into various...

Innovative Brain Imaging Solutions for Neurodegenerative Disorders

Neurodegenerative disorders are a growing concern in today's world. Conditions like Alzheimer's disease, Parkinson's disease, and...

Cutting-Edge Neuro Imaging: Understanding Neurodegenerative Diseases

Neurodegenerative diseases are a growing concern in our aging population. Conditions like Alzheimer's, Parkinson's, and Huntington's...

Advanced Diagnostic Imaging Techniques for Neurodegenerative Diseases

Neurodegenerative diseases are a growing concern in today's world. Conditions like Alzheimer's, Parkinson's, and multiple sclerosis...